{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-03T11:39:32.949582+00:00","company":{"ticker":"COSM","cik":1474167,"company_name":"Cosmos Health Inc."},"pagination":{"limit":100,"returned":8,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"39204e3df6f4d7031f7ae3d2d6fde139f04a3fd6","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2026-04-16T23:59:59+00:00","payload":{"eps_text":"($0.63)","guidance_signal":"none","item_codes_triggered":["2.02"],"net_income_text":"($19.14 million)","period_text":"the full year ended December 31, 2025","report_date":"2026-04-15","result_type":"reported_results","revenue_text":"$65.27 million"},"claim":"Cosmos Health Inc. reported the full year ended December 31, 2025 results: revenue $65.27 million, net income ($19.14 million), EPS ($0.63).","evidence_excerpt":"through Decahedron in the United Kingdom, and the global expansion of proprietary brands, including Sky Premium Life and C-Scrub. Key Metric FY 2025 FY 2024 Change (in $) Revenue 65,271,815 54,426,402 +20 % Gross Profit 7,895,575 4,311,323 +83 % Gross Margin 12.10 % 7.92 % +418 basis points Adjusted EBITDA (3,361,385 ) (3,438,975 ) 2% improvement Adjusted Net Income","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001477932-26-002316","anchor_url":"https://secwatch.observer/filing/0001477932-26-002316#claim-39204e3df6f4d7031f7ae3d2d6fde139f04a3fd6","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793226002316/0001477932-26-002316-index.htm"},{"fact_type":"exchange_compliance_notice","fact_key":"bf600bced1bcc61ffc427deaf30186b220993157","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2025-12-18T23:59:59+00:00","payload":{"company_response":"intends to effect a reverse stock split","compliance_status":"deficient","cure_deadline":"2026-06-09","deficiency_type":"minimum_bid_price","delisting_effective_date":null,"exchange":"nasdaq","hearing_date":null,"immediate_listing_effect":null,"minimum_requirement":null,"notice_date":"2025-12-11","notice_type":"noncompliance_notice","plan_due_date":null,"raw_rule_text":null,"reported_value":null,"rule_numbers":["5550(a)(2)"],"rules_cited_in_text":true},"claim":"Cosmos Health Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"December 11, 2025, Cosmos Health Inc. (the “Company”) received a non-compliance letter from Nasdaq for its failure to maintain a minimum bid price of $1.00 per share for thirty (30) consecutive business days in accordance with Nasdaq Listing Rule 5550(a)(2) (the “Listing Rule”). The Company has one hundred eighty (180) calendar days from December 11, 2025, to regain compliance by maintaining the closing bid price of the Company’s common stock of at least $1.00 per share for a minimum of ten (10) consecutive business days. In the event the Company cannot otherwise regain compliance with the Lis","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-25-009040","anchor_url":"https://secwatch.observer/filing/0001477932-25-009040#claim-bf600bced1bcc61ffc427deaf30186b220993157","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225009040/0001477932-25-009040-index.htm"},{"fact_type":"governance_change","fact_key":"0f08a2fe64a296c900b05ed15a20acc6054cf15b","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2025-10-01T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":null,"item_codes_triggered":["5.03"],"summary_text":"Approved amendment to Articles of Incorporation to increase authorized shares to 1.5B common and 300M blank-check preferred"},"claim":"Cosmos Health Inc.: Approved amendment to Articles of Incorporation to increase authorized shares to 1.5B common and 300M blank-check preferred.","evidence_excerpt":"the Amendment will become effective upon its filing with the Secretary of State of the State of Nevada","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-25-007274","anchor_url":"https://secwatch.observer/filing/0001477932-25-007274#claim-0f08a2fe64a296c900b05ed15a20acc6054cf15b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225007274/0001477932-25-007274-index.htm"},{"fact_type":"debt_financing","fact_key":"4c2522fa7abef77da3cb407521ab9438cd68a21b","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2025-08-06T23:59:59+00:00","payload":{"counterparty":"an institutional investor","effective_date":"2025-08-05","event":"incurrence","instrument_type":"convertible_notes","interest_rate_text":"9% per annum","item_codes_triggered":["2.03"],"maturity_text":"twenty four (24) months after its respective issuance date","principal_text":"$300,000,000"},"claim":"Cosmos Health Inc. incurred convertible notes of $300,000,000 with an institutional investor at 9% per annum maturing twenty four (24) months after its respective issuance date.","evidence_excerpt":"the Company agreed to issue and sell to the Purchaser a series of 9% original issue discount senior secured convertible promissory notes (each, a “ Note ” and collectively, the “ Notes ”) in the maximum aggregate principal amount of $300,000,000 (the “ Note Offering ”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-25-005501","anchor_url":"https://secwatch.observer/filing/0001477932-25-005501#claim-4c2522fa7abef77da3cb407521ab9438cd68a21b","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793225005501/0001477932-25-005501-index.htm"},{"fact_type":"auditor_change","fact_key":"671460b33cb1c9dabeb4a63138f83765e8b9def8","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2024-05-03T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"KPMG Certified Auditors S.A.","disagreement_text":"KPMG has the contrary opinion that there have been disagreements, between KPMG and the Company, on matters of accounting principles or practices, financial statement disclosures, or auditing scope or procedure, and, more specifically, that KPMG has identified certain transactions with a third party consignment vendor that suggested that an illegal act may have occurred","effective_date":"2024-04-26","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Cosmos Health Inc. dismissed KPMG Certified Auditors S.A. as its auditor.","evidence_excerpt":"On April 26, 2024, the Company dismissed KPMG as the Company’s independent registered accountant, effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-002502","anchor_url":"https://secwatch.observer/filing/0001477932-24-002502#claim-671460b33cb1c9dabeb4a63138f83765e8b9def8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793224002502/0001477932-24-002502-index.htm"},{"fact_type":"auditor_change","fact_key":"d259f77881f20e64922ecf09ad0af75546232829","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2024-05-02T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"KPMG Certified Auditors S.A.","disagreement_text":"there were no (a) disagreements with KPMG on any matter of accounting principles or practices, financial statement disclosures, or auditing scope or procedure, which disagreements, if not resolved to KPMG\u0000e2\u0000a0\u0000a2s satisfaction, would have caused KPMG to make reference to the subject matter thereof in connection with its report for such period; or (b) reportable events, as described under Item 304(a)(1)(v) of Regulation S-K. We furnished a copy of the disclosures in this report to KPMG and had requested that KPMG furnish us with a letter addressed to the SEC stating whether such firm agrees with the statements made by the Company in response to this Item 4.01, if not, stating the respects in","effective_date":"2024-04-26","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Cosmos Health Inc. dismissed KPMG Certified Auditors S.A. as its auditor.","evidence_excerpt":"1;) to report the dismissal of KPMG Certified Auditors S.A. (“KPMG”) as the Company’s independent registered public accounting firm, effective immediately, and related matters under Item 4.01 of Form 8-K 0001474167 2024-04-26 2024-04-26 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (AMENDMENT NO. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 26, 2024 Cosmos Health Inc. (Exact name of registrant as specified in its charter) Nevada 000-54436 27-0611758 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 141 West Jackson Blvd , Suite 4236 , Chicago , Illinois 60604 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code ( 312 ) 865-0026 N","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-002483","anchor_url":"https://secwatch.observer/filing/0001477932-24-002483#claim-d259f77881f20e64922ecf09ad0af75546232829","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793224002483/0001477932-24-002483-index.htm"},{"fact_type":"auditor_change","fact_key":"22233100a92a1fc87522550e9816d43342dd6c92","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2024-04-26T23:59:59+00:00","payload":{"action":"dismissal","auditor_name":"KPMG Certified Auditors S.A.","disagreement_text":null,"effective_date":"2024-04-26","item_codes_triggered":["4.01"],"non_reliance_signal":"none","successor_auditor_name":null},"claim":"Cosmos Health Inc. dismissed KPMG Certified Auditors S.A. as its auditor.","evidence_excerpt":"On April 26, 2024, Cosmos Health Inc. (the “Company”) dismissed KPMG Certified Auditors S.A., Athens, Greece, (“KPMG”) as the Company’s independent registered accountant, effective immediately.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-002352","anchor_url":"https://secwatch.observer/filing/0001477932-24-002352#claim-22233100a92a1fc87522550e9816d43342dd6c92","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793224002352/0001477932-24-002352-index.htm"},{"fact_type":"material_agreement","fact_key":"991716845d07a549119b2d133ff678540e1aa47d","cik":1474167,"ticker":"COSM","company_name":"Cosmos Health Inc.","filed_at":"2024-04-25T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Rights Agreement","agreement_type":"other","counterparty":"Globex Transfer, LLC","effective_date":"2024-04-22","item_codes_triggered":["1.01"],"value_text":null},"claim":"Cosmos Health Inc. entered into Rights Agreement with Globex Transfer, LLC (effective 2024-04-22).","evidence_excerpt":"On April 22, 2024, Cosmos Health Inc. (the “Company”) entered into a Rights Agreement (the “Rights Agreement”), by and between the Company and Globex Transfer, LLC, as Rights Agent","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001477932-24-002332","anchor_url":"https://secwatch.observer/filing/0001477932-24-002332#claim-991716845d07a549119b2d133ff678540e1aa47d","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793224002332/0001477932-24-002332-index.htm"}]}